Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre

International Journal of Clinical Practice

Volumn 65, Issue 3, 2011, Pages 299-307

  Mata Cases, M ^a   De Prado Lacueva, C ^a   Salido Valencia, V ^a   Fernandez Bertolin E ^a   Casermeiro Cortes J ^a   Garcia Duran M ^a   Jabalera Lopez S ^a   Fernandez Sanmartin M I ^a  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL DIABETIC NEUROPATHY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STROKE; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK; TUMOR; VASCULAR DISEASE;

AGED; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; EPIDEMIOLOGIC METHODS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SPAIN;

EID: 79951602196     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02503.x     Document Type: Article

References (39)

1. Goday A,. Epidemiología de la diabetes y sus complicaciones no coronarias. Rev Esp Cardiol 2002; 55: 657-70.
2. Deshpande AD, Harris-Hayes M, Schootman M,. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88: 1254-64.
3. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421-31.
4. Gall MA, Rossing P, Skøtt P, et al. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-61.
5. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-22.
6. Gimeno-Orna JA, Molinero-Herguedas E, Sánchez-Vaño R, Lou-Arnal LM, Boned-Juliani B, Castro-Alonso FJ,. Microalbuminuria presents the same vascular risk as overt CVD in type 2 diabetes. Diabetes Res Clin Pract 2006; 74: 103-9. (Pubitemid 44816526)
7. Gimeno-Orna JA, Faure-Nogueras E, Castro-Alonso FJ, Boned-Juliani B,. Ability of retinopathy to predict cardiovascular disease in patients with type 2 diabetes mellitus. Am J Cardiol 2009; 103: 1364-7.
8. Costa B, Cabré JJ, Martín F, et al. La escala de Framingham sobrevalora el riesgo cerebrovascular de la diabetes y el síndrome metabólico en la población española. Aten Primaria 2005; 35: 392-401.
9. Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A,. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up. J Diabetes Complicat 2003; 17: 235-42. (Pubitemid 37040768)
10. Elley CR, Kenealy T, Robinson E, Drury PL,. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabet Med 2008; 25: 1295-301.
11. McAlpine RR, Morris AD, Emslie-Smith A, James P, Evans JM,. The annual incidence of diabetic complications in a population of patients with Type 1 and Type 2 diabetes. Diabet Med 2005; 22: 348-52. (Pubitemid 40313867)
12. Brocco S, Visentin C, Fedeli U, et al. Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases. Cardiovasc Diabetol 2007; 6: 5. doi
13. Ringborg A, Lindgren P, Martinell M, Yin DD, Schön S, StÃlhammar J,. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003-estimates from a Swedish population-based study. Diabet Med 2008; 25: 1178-86.
14. Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA,. Mortality in people with type 2 diabetes in the UK. Diabet Med 2006; 23: 516-21.
15. Standl E, Balletshofer B, Dahl B, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich general practitioner project. Diabetologia 1996; 39: 1540.
16. Brun E, Nelson RG, Bennett PH, et al.; Verona Diabetes Study. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000; 23: 1119-23. (Pubitemid 30616799)
17. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW, Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 2004; 27: 704-8. (Pubitemid 38280537)
18. Lutgers HL, Gerrits EG, Sluiter WJ, et al. Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS ONE 2009; 4: e6817.
19. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the diabetes intervention study, 11year followup. Diabetologia 1996; 39: 1577.
20. Smith NL, Barzilay JI, Kronmal R, Lumley T, Enquobahrie D, Psaty BM,. New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study. Diabetes Care 2006; 29: 2012-7. (Pubitemid 44871179)
21. Guzder RN, Gatling W, Mullee MA, Byrne CD,. Early mortality from the time of diagnosis of Type 2 diabetes: a 5-year prospective cohort study with a local age- and sex-matched comparison cohort. Diabet Med 2007; 24: 1164-7. (Pubitemid 47437880)
22. Guzder RN, Gatling W, Mullee MA, Byrne CD,. Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes. Diabetologia 2006; 49: 49-55. (Pubitemid 43151613)
23. Hillier TA, Pedula KL,. Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003; 26: 2999-3005. (Pubitemid 37345170)
24. Jimeno Mollet J, Molist Brunet N, Franch Nadal J, Serrano Borraz V, Serrano Barragán L, Gracia Giménez R,. Variabilidad en el calculo del riesgo coronario en la diabetes mellitus tipo 2. Aten Primaria 2005; 35: 30-6. (Pubitemid 40293146)
25. Valdés S, Botas P, Delgado E, Díaz Cadórniga F,. Riesgo de mortalidad en diabetes diagnosticada, diabetes no diagnosticada y prediabetes en población adulta española. Estudio Asturias 1998-2004. Rev Esp Cardiol 2009; 62: 528-34.
26. Hu G, DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003; 46: 608-17. (Pubitemid 36808180)
27. Hansen LJ, Olivarius Nde F, Siersma V,. 16-year excess all-cause mortality of newly diagnosed type 2 diabetic patients: a cohort study. BMC Public Health 2009; 9: 400.
28. Saydah S, Tao M, Imperatore G, Gregg E,. GHb level and subsequent mortality among adults in the U.S. Diabetes Care 2009; 32: 1440-6.
29. Harris MI, Klein R, Welborn TA, Knuiman MW,. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-9.
30. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12. (Pubitemid 30609442)
31. Stevens RJ, Kothari V, Adler AI, Stratton IM,. United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-9. (Pubitemid 33135349)
32. Mata-Cases M, Fernández-Bertolín E, Cos-Claramunt X, García-Durán M, Mateu-Gelabert T, Pareja-Rossell C,. Incidencia de diabetes tipo 2 y análisis del proceso diagnóstico en un centro de atención primaria durante la década de los 90. Gac Sanit 2006; 20: 124-31. (Pubitemid 43833892)
33. Mata-Cases M, Fernández-Bertolín E, García- Durán M, Cos-Claramunt X, Pareja-Rossell C, Pujol-Ribera E,. Prevalencia de enfermedad cardiovascular en personas recién diagnosticadas de diabetes tipo 2. Gac Sanit 2009; 23: 133-8.
34. World Health Organization. Diabetes Mellitus. Report of a WHO Study Group. Geneva: World Health Organization, 1985 (Tech. Rep. Ser. no. 727).
35. The expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-6.
36. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Part 1. Report of a WHO Consultation. Geneva (Switzerland): World Health Organization, 1999.
37. D'Agostino RB, Nam BH,. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In:, Balakrishnan N, Rao C, eds. Advances in Survival Analysis: Handbook of Statistics. Amsterdam: Elsevier, 2004: 1-25.
38. Newson R,. Confidence intervals for rank statistics: Somers'D and extensions. Stata J 2006; 6: 309-34. (Pubitemid 44505049)
39. Ungar A, Pepe G, Lambertucci L, et al. Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc 2009; 57: 291-6.